Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Routes for Uveitic CME
NCT02598869Phase 4Withdrawn
- Sponsor
- Oregon Health & Science University
- Start
- Nov 2015
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of triamcinolone acetonide in cystoid macular edema (CME), sponsored by Oregon Health & Science University. Planned start Nov 2015; status: withdrawn.
02
Drugs
triamcinolone acetonide
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT02598869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02598869.